The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

A provision protecting expensive medications, used to treat multiple rare diseases, from the Medicare drug price negotiations ...

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the ...

President Donald Trump’s One Big Beautiful Bill, signed into law last week, reintroduces broader exemptions for orphan drugs from the IRA’s drug price negotiation program—a move welcomed by the ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

The Howard County Board of Education is suing Eli Lilly and Co., Novo Nordisk, CVS, United Health group and several other ...

Guidelines aimed at increasing transparency about how the regulator will evaluate pharmaceutical pricing, official says ...